PCBs May Affect in Vitro Fertilization Outcomes

Released: 21-Feb-2011 9:00 AM EST
Embargo expired: 24-Feb-2011 12:00 AM EST
Source Newsroom: Environmental Health Perspectives (NIEHS)
Contact Information

Available for logged-in reporters only

Implantation failure linked to PCB exposure

Newswise — (RESEARCH TRIANGLE PARK, NC) According to a new study published February 24 in the peer-reviewed journal Environmental Health Perspectives (EHP), serum polychlorinated biphenyls (PCBs) at concentrations found in the general U.S. population are associated with the failure of fertilized embryos to implant in the uterus after in vitro fertilization (IVF). This study may help explain earlier reports of impaired reproduction and increased time to pregnancy among women exposed to PCBs. “Our findings provide insight into a specific time point following conception that determines whether a pregnancy will occur that may be particularly sensitive to PCB exposure,” says lead author John Meeker.

PCBs were banned in the United States and other developed countries in the 1970s, but they persist in the environment due to prior widespread use and resistance to breakdown. Exposure to PCBs occurs mainly through contaminated foods and is associated with adverse health effects, including negative impacts on reproduction.

By conducting the current study with women undergoing IVF, the researchers could examine events during early pregnancy that are difficult or impossible to assess in the general population. “Not only do couples undergoing assisted reproduction represent a growing proportion of the population, but they also provide a unique opportunity to study factors related to very early [pregnancy] losses that usually go undetected and contribute to fertility issues,” Dr. Meeker says.

The women were recruited between August 1994 and June 2003. Blood was collected before each woman’s IVF attempt, and concentrations of 57 individual PCBs were measured in the women’s serum (a component of the blood). Among 765 women and 827 IVF cycles, there were 286 live births and 530 pregnancy losses—229 implantation failures, 177 very early miscarriages (or “chemical pregnancies”), and 124 later miscarriages.

In their analysis, the researchers examined the associations between IVF outcomes and concentrations of individual PCBs known as congeners 118, 138, and 153, as well as the sum of all congeners. PCBs were also grouped according to their structure and biological activity.

After controlling for confounders, the researchers found that implantation failure was twice as likely in women with the highest exposures to PCB-153 and total PCBs than in women with the lowest exposures. The odds of a live birth were reduced more than 40% in these women. The strengths of this study are its prospective design, detailed clinical data, the relatively large number of observations, and the fact that the researchers were able to directly measure women’s PCB levels, which reflected exposures consistent with those in the general population. Limitations include the possibility that women undergoing IVF have a different response to PCBs than women in the general population and the lack of exposure data on the women’s partners.

Co-author Dr. Russ Hauser notes, “Early pregnancy end points were shown in experimental animals to be more sensitive than later end points. Therefore, IVF as a model to study the impact of environmental chemicals on early pregnancy is the only way we can observe these end points in women.”

Other authors of the paper include Arnab Maity, Stacey A. Missmer, Paige L. Williams, Shruthi Mahalingaiah, Shelley Ehrlich, Katharine F. Berry, Larisa Altshul, Melissa J. Perry, and Daniel W. Cramer. Support was provided by the National Institutes of Health, by the National Institute of Environmental Health Sciences, and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

The article “Serum Concentrations of Polychlorinated Biphenyls (PCBs) in Relation to in Vitro Fertilization (IVF) Outcomes” will be available February 24 free of charge at http://ehponline.org/article/info:doi/10.1289/ehp.1002922.

EHP is published by the NIEHS, National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services. EHP is an open-access journal, and all EHP content is available free online at http://www.ehponline.org/. Brogan & Partners Convergence Marketing handles marketing and public relations for the publication and is responsible for creation and distribution of this press release.

Editor’s Note: Working media and other interested parties can register to receive press releases via e-mail by calling 919-653-2583 or e-mailing ehpmedia@brogan.com.


Comment/Share